157 results on '"Mehla, Kamiya"'
Search Results
2. Measurement of Metabolic Alteration in Immune Cells Under Hypoxia
3. Author Correction: Cancer-associated fibroblast-derived acetate promotes pancreatic cancer development by altering polyamine metabolism via the ACSS2–SP1–SAT1 axis
4. SIRT1–NOX4 signaling axis regulates cancer cachexia
5. CD73 induces GM-CSF/MDSC-mediated suppression of T cells to accelerate pancreatic cancer pathogenesis
6. Inflammatory and immune effects on tumor progression
7. The cholesterol pathway: impact on immunity and cancer
8. DHODH inhibition enhances the efficacy of immune checkpoint blockade by increasing cancer cell antigen presentation.
9. The MUC1–HIF-1α signaling axis regulates pancreatic cancer pathogenesis through polyamine metabolism remodeling
10. Supplementary Fig 2 from Vitamin B6 Competition in the Tumor Microenvironment Hampers Antitumor Functions of NK Cells
11. Supplementary Fig 4 from Vitamin B6 Competition in the Tumor Microenvironment Hampers Antitumor Functions of NK Cells
12. Supplementary Fig 7 from Vitamin B6 Competition in the Tumor Microenvironment Hampers Antitumor Functions of NK Cells
13. Supplementary Fig 1 from Vitamin B6 Competition in the Tumor Microenvironment Hampers Antitumor Functions of NK Cells
14. Supplementary Fig 3 from Vitamin B6 Competition in the Tumor Microenvironment Hampers Antitumor Functions of NK Cells
15. Supplementary Fig 5 from Vitamin B6 Competition in the Tumor Microenvironment Hampers Antitumor Functions of NK Cells
16. Supplementary Fig 6 from Vitamin B6 Competition in the Tumor Microenvironment Hampers Antitumor Functions of NK Cells
17. Local and systemic immunosuppression in pancreatic cancer: Targeting the stalwarts in tumor’s arsenal
18. Vitamin B6 Competition in the Tumor Microenvironment Hampers Antitumor Functions of NK Cells
19. Metabolic Regulation of Macrophage Polarization in Cancer
20. Pancreatic Cancer Pathogenesis
21. Inhibition of geranylgeranyl diphosphate synthase is a novel therapeutic strategy for pancreatic ductal adenocarcinoma
22. LXR Signaling-Mediated Cholesterol Metabolism Reprogramming Regulates Cancer Cell Metastasis
23. DHODH inhibition enhances the efficacy of immune checkpoint blockade by increasing cancer cell antigen presentation
24. DHODH inhibition enhances the efficacy of immune checkpoint blockade by increasing cancer cell antigen presentation
25. Supplementary Fig S2 from IgE-Based Therapeutic Combination Enhances Antitumor Response in Preclinical Models of Pancreatic Cancer
26. Combination of mAb-AR20.5, anti-PD-L1 and PolyICLC inhibits tumor progression and prolongs survival of MUC1.Tg mice challenged with pancreatic tumors
27. Evaluation of Macrophage Polarization in Pancreatic Cancer Microenvironment Under Hypoxia
28. MUC1: A novel metabolic master regulator
29. MUC1 mucin stabilizes and activates hypoxia-inducible factor 1 alpha to regulate metabolism in pancreatic cancer
30. RNA Interference Technology — Applications and Limitations
31. Inflammatory and immune effects on tumor progression
32. IgE-Based Therapeutic Combination Enhances Antitumor Response in Preclinical Models of Pancreatic Cancer
33. 654 Analysis of IDO-1 expression on dendritic cells and factors influencing its up- and downregulation in pancreatic cancer
34. Metabolic Rewiring by Loss of Sirt5 Promotes Kras-Induced Pancreatic Cancer Progression
35. Pancreatic Cancer Pathogenesis
36. Heme Oxygenase-1 Inhibition Potentiates the Effects of Nab-Paclitaxel-Gemcitabine and Modulates the Tumor Microenvironment in Pancreatic Ductal Adenocarcinoma
37. Association of a chromosome 1q21 locus in close proximity to a late cornified envelope-like proline-rich 1 (LELP1) gene with total serum IgE levels
38. Preclinical Models for Studying the Impact of Macrophages on Cancer Cachexia
39. Exome Sequencing and Advances in Crop Improvement
40. MicroRNAs in pancreatic cancer metabolism
41. Macrophages potentiate STAT3 signaling in skeletal muscles and regulate pancreatic cancer cachexia
42. Abstract PR15: A novel NK cell-targeted therapeutic strategy against pancreatic cancer
43. Metabolic Subtyping for Novel Personalized Therapies Against Pancreatic Cancer
44. Abstract 1160: Endoplasmic reticulum stress disrupts stemness-related transcriptional regulatory network: Implication for therapy response in cancer
45. A Polymeric Nanogel-Based Treatment Regimen for Enhanced Efficacy and Sequential Administration of Synergistic Drug Combination in Pancreatic Cancer
46. Microscale Gene Expression Analysis of Tumor-Associated Macrophages
47. Combination of mAb-AR20.5, anti-PD-L1 and PolyICLC inhibits tumor progression and prolongs survival of MUC1.Tg mice challenged with pancreatic tumors
48. MUC1 and HIF-1alpha Signaling Crosstalk Induces Anabolic Glucose Metabolism to Impart Gemcitabine Resistance to Pancreatic Cancer
49. Abstract A30: AR20.5-based novel immunotherapy for pancreatic cancer
50. Abstract 10: Silibinin exhibits anti-cachectic and anti-cancerous property by modulating metabolic properties of pancreatic cancer cells
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.